Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients

Journal of Surgical Oncology

Volumn 98, Issue 7, 2008, Pages 545-550

  Brunner, Markus ^a   Thurnher, Dietmar ^a   Heiduschka, Gregor ^a   Grasl, Matthaeus Ch ^a   Brostjan, Christine ^a   Erovic, Boban M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelial progenitor cells; HNSCC; Neovascularisation

Indexed keywords

CD133 ANTIGEN; CD146 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD31 ANTIGEN; CD33 ANTIGEN; CISPLATIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM CELL; ENDOTHELIUM PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOPHARYNX CANCER; LARYNX CANCER; LYMPH NODE METASTASIS; MALE; MOUTH CANCER; NASOPHARYNX CANCER; NEOVASCULARIZATION (PATHOLOGY); OROPHARYNX CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STEM CELL; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; STEM CELLS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 56649089879     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21139     Document Type: Article

References (26)

1. Lin Y, Weisdorf DJ, Solovey A, et al.: Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-77.
2. Beerepoot LV, Mehra N, Linschoten F, et al.: Circulating endothelial cells in cancer patients do not express tissue factor. Cancer Lett 2004;213:241-248.
3. Beerepoot LV, Mehra N, Vermaat JS, et al.: Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 2004;15:139-145.
4. Furstenberger G, von Moos R, Lucas R, et al.: Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. Br J Cancer 2006;94:524-531.
5. Ho JW, Pang RW, Lau C, et al.: Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 2006;44:836-843.
6. Kim HK, Song KS, Kim HO, et al.: Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer. Cancer Lett 2003;198:83-88.
7. Mancuso P, Burlini A, Pruneri G, et al.: Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 2001;97:3658-3661.
8. Zhang H, Vakil V, Braunstein M, et al.: Circulating endothelial progenitor cells in multiple myeloma: Implications and significance. Blood 2005;105:3286-3294.
9. Duda DG, Cohen KS, di Tomaso E, et al.: Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: Implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. J Clin Oncol 2006;24:1449-1453.
10. Shaked Y, Ciarrocchi A, Franco M, et al.: Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006;313:1785-1787.
11. Khan SS, Solomon MA, McCoy JP: Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin Cytom 2005;64:1-8.
12. Goon PK, Boos CJ, Lip GY: Circulating endothelial cells: Markers of vascular dysfunction. Clin Lab 2005;51:531-538.
13. Lyden D, Hattori K, Dias S, et al.: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-1201.
14. Richter-Ehrenstein C, Rentzsch J, Runkel S, et al.: Endothelial progenitor cells in breast cancer patients. Breast Cancer Res Tr 2007;106:343-349.
15. Willett CG, Boucher Y, Duda DG, et al.: Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: Continued experience of a phase I trial in rectal cancer patients. J Clin Oncol 2005;23:8136-8139.
16. Loomans CJ, de Koning EJ, Staal FJ, et al.: Endothelial progenitor cell dysfunction: A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004;53:195-199.
17. Tepper OM, Galiano RD, Capla JM, et al.: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002;106:2781-2786.
18. Westerweel PE, Hoefer IE, Blankestijn PJ, et al.: End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells. Am J Physiol Renal Physiol 2007;292:F1132-F1140.
19. Heeschen C, Lehmann R, Honold J, et al.: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004;109:1615-1622.
20. Massa M, Rosti V, Ferrario M, et al.: Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206.
21. Kondo T, Hayashi M, Takeshita K, et al.: Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004;24:1442-1447.
22. Deschaseaux F, Selmani Z, Falcoz PE, et al.: Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol 2007;562:111-118.
23. Vasa M, Fichtlscherer S, Adler K, et al.: Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001;103:2885-2890.
24. Min TQ, Zhu CJ, Xiang WX, et al.: Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther 2004;18:203-209.
25. Bahlmann FH, de Groot K, Mueller O, et al.: Stimulation of endothelial progenitor cells: A new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005;45:526-529.
26. Bahlmann FH, De Groot K, Spandau JM, et al.: Erythropoietin regulates endothelial progenitor cells. Blood 2004;103:921-926.